Circulating tumor DNA and circulating tumor cells as predictor of outcome in the PRODIGE14-ACCORD21-METHEP2 phase II trial

Annals of Oncology ◽

10.1093/annonc/mdw370.05 ◽

2016 ◽

Vol 27 ◽

pp. vi150 ◽

Cited By ~ 1

Author(s):

F.-C. Bidard ◽

M. Ychou ◽

J. Madic ◽

A. Saliou ◽

O. Bouché ◽

...

Keyword(s):

Tumor Cells ◽

Circulating Tumor Cells ◽

Phase Ii ◽

Phase Ii Trial ◽

Circulating Tumor Dna ◽

Tumor Dna

Download Full-text

Faculty Opinions recommendation of Clinical applications of circulating tumor cells and circulating tumor DNA as liquid biopsy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726213668.793535268 ◽

2017 ◽

Author(s):

Wafik El-Deiry

Keyword(s):

Tumor Cells ◽

Circulating Tumor Cells ◽

Liquid Biopsy ◽

Circulating Tumor Dna ◽

Clinical Applications ◽

Tumor Dna

Download Full-text

Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trial

Annals of Oncology ◽

10.1093/annonc/mdy211 ◽

2018 ◽

Vol 29 (8) ◽

pp. 1777-1783 ◽

Cited By ~ 26

Author(s):

M. Ignatiadis ◽

S. Litière ◽

F. Rothe ◽

S. Riethdorf ◽

C. Proudhon ◽

...

Keyword(s):

Breast Cancer ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Early Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Randomized Phase Ii

Download Full-text

Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer

JAMA Oncology ◽

10.1001/jamaoncol.2020.2295 ◽

2020 ◽

Vol 6 (9) ◽

pp. 1410 ◽

Cited By ~ 8

Author(s):

Milan Radovich ◽

Guanglong Jiang ◽

Bradley A. Hancock ◽

Christopher Chitambar ◽

Rita Nanda ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Disease Recurrence ◽

Circulating Tumor Dna ◽

Tumor Dna

Download Full-text

Circulating tumor cells versus circulating tumor DNA in lung cancer—which one will win?

Translational Lung Cancer Research ◽

10.21037/tlcr.2016.10.02 ◽

2016 ◽

Vol 5 (5) ◽

pp. 466-482 ◽

Cited By ~ 30

Author(s):

Silvia Calabuig-Fariñas ◽

Eloísa Jantus-Lewintre ◽

Alejandro Herreros-Pomares ◽

Carlos Camps

Keyword(s):

Lung Cancer ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Circulating Tumor Dna ◽

Tumor Dna

Download Full-text

The effect of aspirin on circulating tumor cells in metastatic colorectal and breast cancer patients: a phase II trial study

Clinical & Translational Oncology ◽

10.1007/s12094-017-1806-z ◽

2017 ◽

Vol 20 (7) ◽

pp. 912-921 ◽

Cited By ~ 10

Author(s):

L. Yang ◽

Z. Lv ◽

W. Xia ◽

W. Zhang ◽

Y. Xin ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Phase Ii ◽

Phase Ii Trial ◽

Breast Cancer Patients

Download Full-text

Abstract CT194: Exploratory subgroup analysis of atezolizumab (atezo) clinical characteristics in patients (pts) with low circulating tumor DNA (ctDNA) in B-F1RST—a Phase II trial evaluating blood-based tumor mutational burden (bTMB) in NSCLC

10.1158/1538-7445.am2019-ct194 ◽

2019 ◽

Author(s):

Mark A. Socinski ◽

Sarah M. Paul ◽

Cindy Yun ◽

Sylvia Hu ◽

Vincent Shen ◽

...

Keyword(s):

Phase Ii ◽

Subgroup Analysis ◽

Clinical Characteristics ◽

Phase Ii Trial ◽

Circulating Tumor Dna ◽

Mutational Burden ◽

Tumor Mutational Burden ◽

Tumor Dna

Download Full-text

Abstract P2-02-21: The utility and correlation of circulating tumor cells (CTCs) and cell-free circulating tumor DNA (ctDNA) based on HER2 positivity

10.1158/1538-7445.sabcs17-p2-02-21 ◽

2018 ◽

Author(s):

AA Davis ◽

Y Zhang ◽

A Behdad ◽

T Taxter ◽

K Strickland ◽

...

Keyword(s):

Tumor Cells ◽

Circulating Tumor Cells ◽

Circulating Tumor Dna ◽

Tumor Dna ◽

Her2 Positivity

Download Full-text

Immune and Circulating Tumor DNA Profiling After Radiation Treatment for Oligometastatic Non-Small Cell Lung Cancer: Translational Correlatives from a Mature Randomized Phase II Trial

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2019.10.038 ◽

2020 ◽

Vol 106 (2) ◽

pp. 349-357 ◽

Cited By ~ 3

Author(s):

Chad Tang ◽

Won-Chul Lee ◽

Alexandre Reuben ◽

Lianpeng Chang ◽

Hai Tran ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Radiation Treatment ◽

Phase Ii Trial ◽

Circulating Tumor Dna ◽

Small Cell ◽

Small Cell Lung ◽

Randomized Phase Ii ◽

Tumor Dna

Download Full-text

Detection of circulating tumor cells and circulating tumor DNA before and after mammographic breast compression in a cohort of breast cancer patients scheduled for neoadjuvant treatment

Breast Cancer Research and Treatment ◽

10.1007/s10549-019-05326-5 ◽

2019 ◽

Vol 177 (2) ◽

pp. 447-455 ◽

Cited By ~ 4

Author(s):

Daniel Förnvik ◽

Kristina E. Aaltonen ◽

Yilun Chen ◽

Anthony M. George ◽

Christian Brueffer ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Neoadjuvant Treatment ◽

Circulating Tumor Dna ◽

Breast Cancer Patients ◽

Breast Compression ◽

Before And After ◽

Tumor Dna

Download Full-text

Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2011.06.022 ◽

2011 ◽

Vol 123 (1) ◽

pp. 19-26 ◽

Cited By ~ 117

Author(s):

Kian Behbakht ◽

Michael W. Sill ◽

Kathleen M. Darcy ◽

Stephen C. Rubin ◽

Robert S. Mannel ◽

...

Keyword(s):

Tumor Cells ◽

Circulating Tumor Cells ◽

Phase Ii ◽

Mtor Inhibitor ◽

Phase Ii Trial ◽

Gynecologic Oncology ◽

Tumor Biomarkers ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Oncology Group Study

Download Full-text